Excess Renin is Attributed to the Combination of Forward and Backward Failure in HFrEF
ESC Heart Failure · 2024
DOI: 10.1002/ehf2.14731 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift ESC Heart Failure, 2024. Verfasst von Henrike Arfsten und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. Hauptthemen laut MEDLINE: Renin, Heart Failure, Stroke Volume. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Aims
Regulation of the renin-angiotensin system (RAS) in heart failure (HF) with reduced ejection fraction (HFrEF) still raises questions, as a large proportion of patients show normal renin levels despite manifest disease. Experimental venous congestion results in reduced renal perfusion pressure and stimulates renin secretion. We hypothesized that excess renin levels are mainly a result of right ventricular failure as a sequalae of left ventricular dysfunction. The study aimed to link right ventricular function (RVF) with renin levels and to investigate further contributors to excess RAS activation. Methods and results Three hundred thirty-two chronic HFrEF patients undergoing routine ambulatory care were consecutively enrolled in a prospective, registry-based, observational study. Laboratory parameters, including cardiac-specific markers renin, aldosterone, and N-terminal pro-brain natriuretic peptide (NT-proBNP), echocardiographic examination (n = 247), and right heart catheterization (n = 85), were documented. The relationship between renin and its respective parameters was analysed. Renin concentration was not associated with the New York Heart Association class or NT-proBNP. Systolic blood pressure, systemic vascular resistance, serum sodium, aldosterone, and lactate dehydrogenase were associated with increased renin levels (P < 0.035 for all). Renin levels similarly increased with worsening of RVF parameters such as fractional area change, tricuspid annular plane systolic excursion, tissue Doppler imaging, and inferior vena cava diameter (P < 0.011 for all), but not with pulmonary pressure. Excess renin levels were observed when worsening RVF was combined with reduced renal perfusion {625 μIU/mL [interquartile range (IQR): 182–1761] vs. 67 μIU/mL [IQR: 16–231], P < 0.001}, which was associated with worse survival.
Conclusions
While unrelated to classical indices of HF severity, circulating renin levels increase with the worsening of RVF, especially in the combined presence of forward and backward failure. This might explain normal renin levels in HFrEF patients but also excess renin levels in poor haemodynamic conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
ORCID-Profile: Henrike Arfsten, Gregor Heitzinger, Annika Weidenhammer, Georg Goliasch, Philipp E Bartko, Georg Spinka, Noemi Pavo
Zitieren
APA
Arfsten, H., Heitzinger, G., Prausmüller, S., Weidenhammer, A., Goliasch, G., Bartko, P. E., Spinka, G., Hülsmann, M., & Pavo, N. (2024). Excess Renin is Attributed to the Combination of Forward and Backward Failure in HFrEF. ESC Heart Failure. https://doi.org/10.1002/ehf2.14731
Vancouver
Arfsten H, Heitzinger G, Prausmüller S, Weidenhammer A, Goliasch G, Bartko PE, et al. Excess Renin is Attributed to the Combination of Forward and Backward Failure in HFrEF. ESC Heart Failure. 2024. doi:10.1002/ehf2.14731
BibTeX
@article{Arfsten2024,
author = {Arfsten, Henrike and Heitzinger, Gregor and Prausmüller, Suriya and Weidenhammer, Annika and Goliasch, Georg and Bartko, Philipp E and Spinka, Georg and Hülsmann, Martin and Pavo, Noemi},
title = {Excess Renin is Attributed to the Combination of Forward and Backward Failure in HFrEF},
journal = {ESC Heart Failure},
year = {2024},
doi = {10.1002/ehf2.14731}
}
EUVIMED